- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04619901
Palliative Care in Maternity and Neonatology (VESPAN)
May 19, 2026 updated by: University Hospital, Lille
How Parents (and Their Child if They Continue Their Life) Fare After a Decision of Palliative Care Has Been Taken in the Neonatal Period
Palliative care is now an accepted principle in most maternity and neonatology wards, however not much is known about its psychological and social consequences on families.
Some children continue their life after a palliative care decision has been taken.
In France, quality of life and the neuro-developmental evolution of newborns who continue their life after a palliative care decision has been taken, have never been studied.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arras, France
- CH Arras
-
Lens, France
- CH Lens
-
Lille, France, 59037
- Hop Jeanne de Flandre Chu Lille
-
Valenciennes, France
- CH Valenciennes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
children and parents followed in pediatric unit whom a decision of palliative care has been made in the neonatal period
Description
Inclusion Criteria:
- Father and/or Mother of a child, who is alive or not, for whom a decision of palliative care has been made in the neonatal period
- Under the care of one of the Level 3 Maternity Centers in the North and Pas-de-Calais departments (Arras, Lens, Lille, Valenciennes) since 2018
- Written consent of the two legal guardians of the child allowing the collection of data concerning the child
- Written consent of the parent(s) participating to this study by completing the parental questionnaires
Exclusion Criteria:
- Medico-legal complaint underway
- Parents who do not understand French
- Parents or children who are under legal protection (guardianship, curatorship)
- Parents or children who are not Social Security beneficiaries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Parents only
|
Exploring the psychological and social impact on parents of a palliative care decision concerning their child in the neonatal period
Assessing the neuro-developmental evolution of children and understanding the determinants of the psychological and social impact of palliative care decisions on parents
Scales : Hospital Anxiety and Depression, Intolerance to Uncertainty, and Brief COPE.
|
|
Children and Parents
|
Assessing the neuro-developmental evolution of children and understanding the determinants of the psychological and social impact of palliative care decisions on parents
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Semi Structured interview
Time Frame: 24 months after palliative care decision
|
Parents : Exploring the psychological and social impact of the palliative care decision 2 hours semi structured interviews will be done to describe the psychological and social impact a decision of palliative care concerning their newborn infant has on parents.
|
24 months after palliative care decision
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ages and Stages Questionnaire (ASQ) - Clinical Examination of Child
Time Frame: 24 months after palliative care decision
|
Child : Neuro-Developmental Assessment
|
24 months after palliative care decision
|
|
Semi Structured Interview
Time Frame: 24 months after palliative care decision
|
Parents : Determinants of the psychological and social impact of the palliative care decision
|
24 months after palliative care decision
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 24 months after palliative care decision
|
Parents :Psychometric Measure of Anxiety and Depression The scale allows to detect anxiety and depression using 14 items rated from 0-3.
|
24 months after palliative care decision
|
|
Intolerance to Uncertainty Scale (EEI)
Time Frame: 24 months after palliative care decision
|
Parents : Psychometric Measure of Intolerance to Uncertainty This questionnaire contains 27 items measuring emotions, cognitions and behaviours in ambiguous situations, the consequences of being uncertain and attempts to control the future.Items are rated on a Likert scale from 1 ("Not at all matching") to 5 ("Very matching").
The total share is obtained by adding the items.
|
24 months after palliative care decision
|
|
Brief COPE
Time Frame: 24 months after palliative care decision
|
Parents : Psychometric Measure of Coping Strategies The Brief-COPE is a 28 item self-report questionnaire withs scoring and interpretation: Positive reframing / Planning/ Humor / Religion/Self-blame
|
24 months after palliative care decision
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laurent Storme, MD,PhD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 12, 2020
Primary Completion (Actual)
August 31, 2023
Study Completion (Actual)
August 31, 2023
Study Registration Dates
First Submitted
October 14, 2020
First Submitted That Met QC Criteria
November 5, 2020
First Posted (Actual)
November 6, 2020
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 19, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017_14
- 2018-A01226-49 (Other Identifier: ID-RCB number, ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.